Back to company

Scanbio Denmark ApS: Financial statements 2021

CVR: 42107654

Scanbio Denmark ApS (CVR 42107654) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 2,484,644 and a net result of DKK 447,682. Equity amounted to DKK 487,682. The solvency ratio was 2.4%. The company had 3 employees in the financial year.

Gross Profit
2,484,644 kr.
Profit/Loss
447,682 kr.
Equity
487,682 kr.
Total Assets
20,544,187 kr.
Employees
3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Scanbio Denmark ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Kamel Gabriel El Khaloui joins Scanbio Denmark ApS as directorOct 8, 2021

As of October 8, 2021, Kamel Gabriel El Khaloui is registered as director of Scanbio Denmark ApS.

Karsten Himmelstrup steps down as director of Scanbio Denmark ApSOct 8, 2021

As of October 8, 2021, Karsten Himmelstrup has stepped down as director of Scanbio Denmark ApS.

Karsten Himmelstrup joins Scanbio Denmark ApS as directorFeb 8, 2021

As of February 8, 2021, Karsten Himmelstrup is registered as director of Scanbio Denmark ApS.

Registered as owner of Scanbio Denmark ApSFeb 8, 2021

As of February 8, 2021, is registered as an owner of Scanbio Denmark ApS with an ownership share of 100%.

Scanbio Denmark ApS is foundedFeb 8, 2021

Scanbio Denmark ApS was founded on February 8, 2021.

About Scanbio Denmark ApS

Scanbio Denmark ApS is a Danish company of the type Anpartsselskab based in Nexø, founded in 2021. The company is registered under the industry Forarbejdning og konservering af fisk, krebsdyr og bløddyr, undtagen fiskemel. The management consists of Tor Vikenes. The company is owned by Scanbio Ingredients AS. In 2025, the company reported a gross profit of DKK 5,295,465 and a net result of DKK -135,927 compared with DKK 1,999,265 the year before. Equity amounted to DKK 10,249,140.

Other financial years